One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
Clinical trial NCT01113541 · TERMINATED
Trial details
- NCT number
- NCT01113541
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-02-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.